 | • レポートコード：MRC2012B0852 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、ナチュラルキラー細胞療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。ナチュラルキラー細胞療法の種類別市場規模（NK細胞療法、NK細胞指向抗体）、用途別市場規模（がん、胃腸疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Nektar Therapeutics、Kiadis Pharma、Chipscreen Biosciences、Innate Pharma SA、Dragonfly Therapeutics、Affimed、NantKwest、Fate Therapeutics、Glycostem Therapeutics、Nkarta Therapeutics ・地域別グローバル市場分析 2015年-2020年 ・ナチュラルキラー細胞療法の北米市場（アメリカ、カナダ、メキシコ） ・ナチュラルキラー細胞療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ナチュラルキラー細胞療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ナチュラルキラー細胞療法の南米市場（ブラジル、アルゼンチン） ・ナチュラルキラー細胞療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：NK細胞療法、NK細胞指向抗体 ・用途別分析：がん、胃腸疾患、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Natural Killer Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Natural Killer Cell Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 23.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 399.9 million by 2025, from USD 173.8 million in 2019.
Market segmentation
Natural Killer Cell Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Natural Killer Cell Therapy market has been segmented into:
NK Cell Therapies
NK Cell Directed Antibodies
By Application, Natural Killer Cell Therapy has been segmented into:
Cancer
Gastrointestinal Diseases
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Natural Killer Cell Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Natural Killer Cell Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Natural Killer Cell Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Natural Killer Cell Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Natural Killer Cell Therapy Market Share Analysis
Natural Killer Cell Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Natural Killer Cell Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Natural Killer Cell Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Natural Killer Cell Therapy are:
Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate Pharma SA
Dragonfly Therapeutics
Affimed
NantKwest
Fate Therapeutics
Glycostem Therapeutics
Nkarta Therapeutics
Among other players domestic and global, Natural Killer Cell Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Natural Killer Cell Therapy Market Overview
1.1 Product Overview and Scope of Natural Killer Cell Therapy
1.2 Classification of Natural Killer Cell Therapy by Type
1.2.1 Global Natural Killer Cell Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Natural Killer Cell Therapy Revenue Market Share by Type in 2019
1.2.3 NK Cell Therapies
1.2.4 NK Cell Directed Antibodies
1.3 Global Natural Killer Cell Therapy Market by Application
1.3.1 Overview: Global Natural Killer Cell Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Global Natural Killer Cell Therapy Market by Regions
1.4.1 Global Natural Killer Cell Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Natural Killer Cell Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Natural Killer Cell Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Natural Killer Cell Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Natural Killer Cell Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Natural Killer Cell Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Natural Killer Cell Therapy Status and Prospect (2015-2025)
2 Company Profiles
2.1 Nektar Therapeutics
2.1.1 Nektar Therapeutics Details
2.1.2 Nektar Therapeutics Major Business
2.1.3 Nektar Therapeutics SWOT Analysis
2.1.4 Nektar Therapeutics Product and Services
2.1.5 Nektar Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Kiadis Pharma
2.2.1 Kiadis Pharma Details
2.2.2 Kiadis Pharma Major Business
2.2.3 Kiadis Pharma SWOT Analysis
2.2.4 Kiadis Pharma Product and Services
2.2.5 Kiadis Pharma Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 Chipscreen Biosciences
2.3.1 Chipscreen Biosciences Details
2.3.2 Chipscreen Biosciences Major Business
2.3.3 Chipscreen Biosciences SWOT Analysis
2.3.4 Chipscreen Biosciences Product and Services
2.3.5 Chipscreen Biosciences Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Innate Pharma SA
2.4.1 Innate Pharma SA Details
2.4.2 Innate Pharma SA Major Business
2.4.3 Innate Pharma SA SWOT Analysis
2.4.4 Innate Pharma SA Product and Services
2.4.5 Innate Pharma SA Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 Dragonfly Therapeutics
2.5.1 Dragonfly Therapeutics Details
2.5.2 Dragonfly Therapeutics Major Business
2.5.3 Dragonfly Therapeutics SWOT Analysis
2.5.4 Dragonfly Therapeutics Product and Services
2.5.5 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Affimed
2.6.1 Affimed Details
2.6.2 Affimed Major Business
2.6.3 Affimed Product and Services
2.6.4 Affimed Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.7 NantKwest
2.7.1 NantKwest Details
2.7.2 NantKwest Major Business
2.7.3 NantKwest Product and Services
2.7.4 NantKwest Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.8 Fate Therapeutics
2.8.1 Fate Therapeutics Details
2.8.2 Fate Therapeutics Major Business
2.8.3 Fate Therapeutics Product and Services
2.8.4 Fate Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.9 Glycostem Therapeutics
2.9.1 Glycostem Therapeutics Details
2.9.2 Glycostem Therapeutics Major Business
2.9.3 Glycostem Therapeutics Product and Services
2.9.4 Glycostem Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.10 Nkarta Therapeutics
2.10.1 Nkarta Therapeutics Details
2.10.2 Nkarta Therapeutics Major Business
2.10.3 Nkarta Therapeutics Product and Services
2.10.4 Nkarta Therapeutics Natural Killer Cell Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Natural Killer Cell Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Natural Killer Cell Therapy Players Market Share
3.2.2 Top 10 Natural Killer Cell Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Natural Killer Cell Therapy Revenue and Market Share by Regions
4.2 North America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
4.5 South America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
5 North America Natural Killer Cell Therapy Revenue by Countries
5.1 North America Natural Killer Cell Therapy Revenue by Countries (2015-2020)
5.2 USA Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
6 Europe Natural Killer Cell Therapy Revenue by Countries
6.1 Europe Natural Killer Cell Therapy Revenue by Countries (2015-2020)
6.2 Germany Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
6.3 UK Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
6.4 France Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Natural Killer Cell Therapy Revenue by Countries
7.1 Asia-Pacific Natural Killer Cell Therapy Revenue by Countries (2015-2020)
7.2 China Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
7.5 India Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
8 South America Natural Killer Cell Therapy Revenue by Countries
8.1 South America Natural Killer Cell Therapy Revenue by Countries (2015-2020)
8.2 Brazil Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Natural Killer Cell Therapy by Countries
9.1 Middle East & Africa Natural Killer Cell Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Natural Killer Cell Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global Natural Killer Cell Therapy Market Forecast by Type (2019-2024)
10.3 NK Cell Therapies Revenue Growth Rate (2015-2025)
10.4 NK Cell Directed Antibodies Revenue Growth Rate (2015-2025)
11 Global Natural Killer Cell Therapy Market Segment by Application
11.1 Global Natural Killer Cell Therapy Revenue Market Share by Application (2015-2020)
11.2 Natural Killer Cell Therapy Market Forecast by Application (2019-2024)
11.3 Cancer Revenue Growth (2015-2020)
11.4 Gastrointestinal Diseases Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Natural Killer Cell Therapy Market Size Forecast (2021-2025)
12.1 Global Natural Killer Cell Therapy Market Size Forecast (2021-2025)
12.2 Global Natural Killer Cell Therapy Market Forecast by Regions (2021-2025)
12.3 North America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
12.4 Europe Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
12.6 South America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Natural Killer Cell Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Natural Killer Cell Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Natural Killer Cell Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Natural Killer Cell Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Natural Killer Cell Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Nektar Therapeutics Corporate Information, Location and Competitors
Table 7. Nektar Therapeutics Natural Killer Cell Therapy Major Business
Table 8. Nektar Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Nektar Therapeutics SWOT Analysis
Table 10. Nektar Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 11. Nektar Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Kiadis Pharma Corporate Information, Location and Competitors
Table 13. Kiadis Pharma Natural Killer Cell Therapy Major Business
Table 14. Kiadis Pharma Natural Killer Cell Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Kiadis Pharma SWOT Analysis
Table 16. Kiadis Pharma Natural Killer Cell Therapy Product and Solutions
Table 17. Kiadis Pharma Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Chipscreen Biosciences Corporate Information, Location and Competitors
Table 19. Chipscreen Biosciences Natural Killer Cell Therapy Major Business
Table 20. Chipscreen Biosciences Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 21. Chipscreen Biosciences SWOT Analysis
Table 22. Chipscreen Biosciences Natural Killer Cell Therapy Product and Solutions
Table 23. Chipscreen Biosciences Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Innate Pharma SA Corporate Information, Location and Competitors
Table 25. Innate Pharma SA Natural Killer Cell Therapy Major Business
Table 26. Innate Pharma SA Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Innate Pharma SA SWOT Analysis
Table 28. Innate Pharma SA Natural Killer Cell Therapy Product and Solutions
Table 29. Innate Pharma SA Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Dragonfly Therapeutics Corporate Information, Location and Competitors
Table 31. Dragonfly Therapeutics Natural Killer Cell Therapy Major Business
Table 32. Dragonfly Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 33. Dragonfly Therapeutics SWOT Analysis
Table 34. Dragonfly Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 35. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Affimed Corporate Information, Location and Competitors
Table 37. Affimed Natural Killer Cell Therapy Major Business
Table 38. Affimed Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Affimed SWOT Analysis
Table 40. Affimed Natural Killer Cell Therapy Product and Solutions
Table 41. Affimed Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. NantKwest Corporate Information, Location and Competitors
Table 43. NantKwest Natural Killer Cell Therapy Major Business
Table 44. NantKwest Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 45. NantKwest SWOT Analysis
Table 46. NantKwest Natural Killer Cell Therapy Product and Solutions
Table 47. NantKwest Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Fate Therapeutics Corporate Information, Location and Competitors
Table 49. Fate Therapeutics Natural Killer Cell Therapy Major Business
Table 50. Fate Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 51. Fate Therapeutics SWOT Analysis
Table 52. Fate Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 53. Fate Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Glycostem Therapeutics Corporate Information, Location and Competitors
Table 55. Glycostem Therapeutics Natural Killer Cell Therapy Major Business
Table 56. Glycostem Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 57. Glycostem Therapeutics SWOT Analysis
Table 58. Glycostem Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 59. Glycostem Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Nkarta Therapeutics Corporate Information, Location and Competitors
Table 61. Nkarta Therapeutics Natural Killer Cell Therapy Major Business
Table 62. Nkarta Therapeutics Natural Killer Cell Therapy Total Revenue (USD Million) (2017-2018)
Table 63. Nkarta Therapeutics SWOT Analysis
Table 64. Nkarta Therapeutics Natural Killer Cell Therapy Product and Solutions
Table 65. Nkarta Therapeutics Natural Killer Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global Natural Killer Cell Therapy Revenue (Million USD) by Players (2015-2020)
Table 67. Global Natural Killer Cell Therapy Revenue Share by Players (2015-2020)
Table 68. Global Natural Killer Cell Therapy Revenue (Million USD) by Regions (2015-2020)
Table 69. Global Natural Killer Cell Therapy Revenue Market Share by Regions (2015-2020)
Table 70. North America Natural Killer Cell Therapy Revenue by Countries (2015-2020)
Table 71. North America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 72. Europe Natural Killer Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific Natural Killer Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 74. South America Natural Killer Cell Therapy Revenue by Countries (2015-2020)
Table 75. South America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa Natural Killer Cell Therapy Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Table 78. Global Natural Killer Cell Therapy Revenue (Million USD) by Type (2015-2020)
Table 79. Global Natural Killer Cell Therapy Revenue Share by Type (2015-2020)
Table 80. Global Natural Killer Cell Therapy Revenue Forecast by Type (2021-2025)
Table 81. Global Natural Killer Cell Therapy Revenue by Application (2015-2020)
Table 82. Global Natural Killer Cell Therapy Revenue Share by Application (2015-2020)
Table 83. Global Natural Killer Cell Therapy Revenue Forecast by Application (2021-2025)
Table 84. Global Natural Killer Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Natural Killer Cell Therapy Picture
Figure 2. Global Natural Killer Cell Therapy Revenue Market Share by Type in 2019
Figure 3. NK Cell Therapies Picture
Figure 4. NK Cell Directed Antibodies Picture
Figure 5. Natural Killer Cell Therapy Revenue Market Share by Application in 2019
Figure 6. Cancer Picture
Figure 7. Gastrointestinal Diseases Picture
Figure 8. Others Picture
Figure 9. Global Natural Killer Cell Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Natural Killer Cell Therapy Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Natural Killer Cell Therapy Revenue Market Share in 2019
Figure 18. Global Top 10 Players Natural Killer Cell Therapy Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Natural Killer Cell Therapy Revenue Market Share by Regions (2015-2020)
Figure 22. Global Natural Killer Cell Therapy Revenue Market Share by Regions in 2018
Figure 23. North America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 24. Europe Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 26. South America Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 28. North America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 29. North America Natural Killer Cell Therapy Revenue Market Share by Countries in 2019
Figure 30. USA Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 31. Canada Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Europe Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Natural Killer Cell Therapy Revenue Market Share by Countries in 2019
Figure 35. Germany Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 36. UK Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 37. France Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 38. Russia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Italy Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Natural Killer Cell Therapy Revenue Market Share by Countries in 2019
Figure 42. China Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 43. Japan Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Korea Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 45. India Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 47. South America Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 48. South America Natural Killer Cell Therapy Revenue Market Share by Countries in 2019
Figure 49. Brazil Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Natural Killer Cell Therapy Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 54. UAE Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Natural Killer Cell Therapy Revenue and Growth Rate (2015-2020)
Figure 57. Global Natural Killer Cell Therapy Revenue Share by Type (2015-2020)
Figure 58. Global Natural Killer Cell Therapy Revenue Share by Type in 2019
Figure 59. Global Natural Killer Cell Therapy Market Share Forecast by Type (2021-2025)
Figure 60. Global NK Cell Therapies Revenue Growth Rate (2015-2020)
Figure 61. Global NK Cell Directed Antibodies Revenue Growth Rate (2015-2020)
Figure 62. Global Natural Killer Cell Therapy Revenue Share by Application (2015-2020)
Figure 63. Global Natural Killer Cell Therapy Revenue Share by Application in 2019
Figure 64. Global Natural Killer Cell Therapy Market Share Forecast by Application (2021-2025)
Figure 65. Global Cancer Revenue Growth Rate (2015-2020)
Figure 66. Global Gastrointestinal Diseases Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Natural Killer Cell Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Natural Killer Cell Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Natural Killer Cell Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
Figure 72. Europe Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
Figure 74. South America Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Natural Killer Cell Therapy Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
ナチュラルキラー細胞療法の世界市場（～2026年） Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destr…- 変形性関節症における幹細胞治療の世界市場（～2026年） Osteoarthritis is one of the chronic conditions for joints which results in the breakdown and eventual loss of the cartilage of one or more joints. This can affect joints including hips, lower back, neck, small joints of the fingers, and the base of the thumb and big toe. The expected growth is beca…
- 多発性骨髄腫に対するCAR-T細胞療法の世界市場（～2026年） CARs are also known as chimeric immunoreceptors, chimeric T-cell receptors, artificial T-cell receptors or CAR T. they are used as an individual's own cells and re-engineers them to fight cancer. Though the market has witnessed several positive results of the clinical trial in the recent years, it i…
- がん幹細胞治療の世界市場（～2026年） Market Analysis and Insights: Global Cancer Stem Cell Therapy Market The global Cancer Stem Cell Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cancer Stem Cell Therapy Scope and Market Size Cancer Stem Cell T…
- 犬幹細胞治療の世界市場（～2026年） The non-invasive stem cell obtaining procedure, augmented possibility of accomplishing high quality cells, and lower price of therapy coupled with high success rate of positive outcomes have collectively made allogeneic stem cell therapy a preference for veterinary physicians. Moreover, allogeneic s…